ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aurora Kinase B Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-20X7124
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Aurora Kinase B Market Insights Forecast to 2028
BUY CHAPTERS

Global Aurora Kinase B Market Research Report 2025

Code: QYRE-Auto-20X7124
Report
September 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
Astrazeneca plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc

Aurora Kinase B Market

The global market for Aurora Kinase B was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Aurora Kinase B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Aurora Kinase B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Aurora Kinase B include AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sanofi, Sareum Holdings Plc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aurora Kinase B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aurora Kinase B.
The Aurora Kinase B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aurora Kinase B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aurora Kinase B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Aurora Kinase B Market Report

Report Metric Details
Report Name Aurora Kinase B Market
Segment by Type
  • AZD-2811
  • CS-2164
  • Danusertib
  • Ilorasertib
  • NMI-900
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sanofi, Sareum Holdings Plc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Aurora Kinase B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Aurora Kinase B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Aurora Kinase B Market report?

Ans: The main players in the Aurora Kinase B Market are AbbVie Inc, Advenchen Laboratories LLC, Aeterna Zentaris Inc, Amgen Inc, AstraZeneca Plc, Chipscreen Biosciences Ltd, Cielo Therapeutics Inc, Sanofi, Sareum Holdings Plc

What are the Application segmentation covered in the Aurora Kinase B Market report?

Ans: The Applications covered in the Aurora Kinase B Market report are Anaplastic Large Cell Lymphoma, Kidney Cancer, Lung Cancer, Prostate Cancer, Others

What are the Type segmentation covered in the Aurora Kinase B Market report?

Ans: The Types covered in the Aurora Kinase B Market report are AZD-2811, CS-2164, Danusertib, Ilorasertib, NMI-900, Others

Recommended Reports

Kinase Inhibitor Markets

Cancer Therapeutics

Targeted Oncology Drugs

1 Aurora Kinase B Market Overview
1.1 Product Definition
1.2 Aurora Kinase B by Type
1.2.1 Global Aurora Kinase B Market Value Comparison by Type (2024 VS 2031)
1.2.2 AZD-2811
1.2.3 CS-2164
1.2.4 Danusertib
1.2.5 Ilorasertib
1.2.6 NMI-900
1.2.7 Others
1.3 Aurora Kinase B by Application
1.3.1 Global Aurora Kinase B Market Value by Application (2024 VS 2031)
1.3.2 Anaplastic Large Cell Lymphoma
1.3.3 Kidney Cancer
1.3.4 Lung Cancer
1.3.5 Prostate Cancer
1.3.6 Others
1.4 Global Aurora Kinase B Market Size Estimates and Forecasts
1.4.1 Global Aurora Kinase B Revenue 2020-2031
1.4.2 Global Aurora Kinase B Sales 2020-2031
1.4.3 Global Aurora Kinase B Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Aurora Kinase B Market Competition by Manufacturers
2.1 Global Aurora Kinase B Sales Market Share by Manufacturers (2020-2025)
2.2 Global Aurora Kinase B Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Aurora Kinase B Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Aurora Kinase B, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Aurora Kinase B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Aurora Kinase B, Product Type & Application
2.7 Global Key Manufacturers of Aurora Kinase B, Date of Enter into This Industry
2.8 Global Aurora Kinase B Market Competitive Situation and Trends
2.8.1 Global Aurora Kinase B Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Aurora Kinase B Players Market Share by Revenue
2.8.3 Global Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Aurora Kinase B Market Scenario by Region
3.1 Global Aurora Kinase B Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Aurora Kinase B Sales by Region: 2020-2031
3.2.1 Global Aurora Kinase B Sales by Region: 2020-2025
3.2.2 Global Aurora Kinase B Sales by Region: 2026-2031
3.3 Global Aurora Kinase B Revenue by Region: 2020-2031
3.3.1 Global Aurora Kinase B Revenue by Region: 2020-2025
3.3.2 Global Aurora Kinase B Revenue by Region: 2026-2031
3.4 North America Aurora Kinase B Market Facts & Figures by Country
3.4.1 North America Aurora Kinase B Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Aurora Kinase B Sales by Country (2020-2031)
3.4.3 North America Aurora Kinase B Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Aurora Kinase B Market Facts & Figures by Country
3.5.1 Europe Aurora Kinase B Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Aurora Kinase B Sales by Country (2020-2031)
3.5.3 Europe Aurora Kinase B Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Aurora Kinase B Market Facts & Figures by Region
3.6.1 Asia Pacific Aurora Kinase B Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Aurora Kinase B Sales by Region (2020-2031)
3.6.3 Asia Pacific Aurora Kinase B Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Aurora Kinase B Market Facts & Figures by Country
3.7.1 Latin America Aurora Kinase B Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Aurora Kinase B Sales by Country (2020-2031)
3.7.3 Latin America Aurora Kinase B Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Aurora Kinase B Market Facts & Figures by Country
3.8.1 Middle East and Africa Aurora Kinase B Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Aurora Kinase B Sales by Country (2020-2031)
3.8.3 Middle East and Africa Aurora Kinase B Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Aurora Kinase B Sales by Type (2020-2031)
4.1.1 Global Aurora Kinase B Sales by Type (2020-2025)
4.1.2 Global Aurora Kinase B Sales by Type (2026-2031)
4.1.3 Global Aurora Kinase B Sales Market Share by Type (2020-2031)
4.2 Global Aurora Kinase B Revenue by Type (2020-2031)
4.2.1 Global Aurora Kinase B Revenue by Type (2020-2025)
4.2.2 Global Aurora Kinase B Revenue by Type (2026-2031)
4.2.3 Global Aurora Kinase B Revenue Market Share by Type (2020-2031)
4.3 Global Aurora Kinase B Price by Type (2020-2031)
5 Segment by Application
5.1 Global Aurora Kinase B Sales by Application (2020-2031)
5.1.1 Global Aurora Kinase B Sales by Application (2020-2025)
5.1.2 Global Aurora Kinase B Sales by Application (2026-2031)
5.1.3 Global Aurora Kinase B Sales Market Share by Application (2020-2031)
5.2 Global Aurora Kinase B Revenue by Application (2020-2031)
5.2.1 Global Aurora Kinase B Revenue by Application (2020-2025)
5.2.2 Global Aurora Kinase B Revenue by Application (2026-2031)
5.2.3 Global Aurora Kinase B Revenue Market Share by Application (2020-2031)
5.3 Global Aurora Kinase B Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie Inc
6.1.1 AbbVie Inc Company Information
6.1.2 AbbVie Inc Description and Business Overview
6.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Inc Aurora Kinase B Product Portfolio
6.1.5 AbbVie Inc Recent Developments/Updates
6.2 Advenchen Laboratories LLC
6.2.1 Advenchen Laboratories LLC Company Information
6.2.2 Advenchen Laboratories LLC Description and Business Overview
6.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Advenchen Laboratories LLC Aurora Kinase B Product Portfolio
6.2.5 Advenchen Laboratories LLC Recent Developments/Updates
6.3 Aeterna Zentaris Inc
6.3.1 Aeterna Zentaris Inc Company Information
6.3.2 Aeterna Zentaris Inc Description and Business Overview
6.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aeterna Zentaris Inc Aurora Kinase B Product Portfolio
6.3.5 Aeterna Zentaris Inc Recent Developments/Updates
6.4 Amgen Inc
6.4.1 Amgen Inc Company Information
6.4.2 Amgen Inc Description and Business Overview
6.4.3 Amgen Inc Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Amgen Inc Aurora Kinase B Product Portfolio
6.4.5 Amgen Inc Recent Developments/Updates
6.5 AstraZeneca Plc
6.5.1 AstraZeneca Plc Company Information
6.5.2 AstraZeneca Plc Description and Business Overview
6.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.5.4 AstraZeneca Plc Aurora Kinase B Product Portfolio
6.5.5 AstraZeneca Plc Recent Developments/Updates
6.6 Chipscreen Biosciences Ltd
6.6.1 Chipscreen Biosciences Ltd Company Information
6.6.2 Chipscreen Biosciences Ltd Description and Business Overview
6.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Chipscreen Biosciences Ltd Aurora Kinase B Product Portfolio
6.6.5 Chipscreen Biosciences Ltd Recent Developments/Updates
6.7 Cielo Therapeutics Inc
6.7.1 Cielo Therapeutics Inc Company Information
6.7.2 Cielo Therapeutics Inc Description and Business Overview
6.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cielo Therapeutics Inc Aurora Kinase B Product Portfolio
6.7.5 Cielo Therapeutics Inc Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Company Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sanofi Aurora Kinase B Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Sareum Holdings Plc
6.9.1 Sareum Holdings Plc Company Information
6.9.2 Sareum Holdings Plc Description and Business Overview
6.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sareum Holdings Plc Aurora Kinase B Product Portfolio
6.9.5 Sareum Holdings Plc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Aurora Kinase B Industry Chain Analysis
7.2 Aurora Kinase B Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Aurora Kinase B Production Mode & Process Analysis
7.4 Aurora Kinase B Sales and Marketing
7.4.1 Aurora Kinase B Sales Channels
7.4.2 Aurora Kinase B Distributors
7.5 Aurora Kinase B Customer Analysis
8 Aurora Kinase B Market Dynamics
8.1 Aurora Kinase B Industry Trends
8.2 Aurora Kinase B Market Drivers
8.3 Aurora Kinase B Market Challenges
8.4 Aurora Kinase B Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
AbbVie
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Amgen Inc
Astrazeneca plc
Chipscreen Biosciences Ltd
Cielo Therapeutics Inc
Sanofi
Sareum Holdings Plc
List of Tables
 Table 1. Global Aurora Kinase B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Aurora Kinase B Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Aurora Kinase B Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Aurora Kinase B Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Aurora Kinase B Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Aurora Kinase B Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Aurora Kinase B Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Aurora Kinase B Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Aurora Kinase B, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Aurora Kinase B, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Aurora Kinase B, Product Type & Application
 Table 12. Global Key Manufacturers of Aurora Kinase B, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Aurora Kinase B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aurora Kinase B as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Aurora Kinase B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Aurora Kinase B Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Aurora Kinase B Sales Market Share by Region (2020-2025)
 Table 19. Global Aurora Kinase B Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Aurora Kinase B Sales Market Share by Region (2026-2031)
 Table 21. Global Aurora Kinase B Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Aurora Kinase B Revenue Market Share by Region (2020-2025)
 Table 23. Global Aurora Kinase B Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Aurora Kinase B Revenue Market Share by Region (2026-2031)
 Table 25. North America Aurora Kinase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Aurora Kinase B Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Aurora Kinase B Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Aurora Kinase B Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Aurora Kinase B Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Aurora Kinase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Aurora Kinase B Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Aurora Kinase B Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Aurora Kinase B Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Aurora Kinase B Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Aurora Kinase B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Aurora Kinase B Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Aurora Kinase B Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Aurora Kinase B Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Aurora Kinase B Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Aurora Kinase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Aurora Kinase B Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Aurora Kinase B Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Aurora Kinase B Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Aurora Kinase B Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Aurora Kinase B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Aurora Kinase B Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Aurora Kinase B Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Aurora Kinase B Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Aurora Kinase B Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Aurora Kinase B Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Aurora Kinase B Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Aurora Kinase B Sales Market Share by Type (2020-2025)
 Table 53. Global Aurora Kinase B Sales Market Share by Type (2026-2031)
 Table 54. Global Aurora Kinase B Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Aurora Kinase B Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Aurora Kinase B Revenue Market Share by Type (2020-2025)
 Table 57. Global Aurora Kinase B Revenue Market Share by Type (2026-2031)
 Table 58. Global Aurora Kinase B Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Aurora Kinase B Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Aurora Kinase B Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Aurora Kinase B Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Aurora Kinase B Sales Market Share by Application (2020-2025)
 Table 63. Global Aurora Kinase B Sales Market Share by Application (2026-2031)
 Table 64. Global Aurora Kinase B Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Aurora Kinase B Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Aurora Kinase B Revenue Market Share by Application (2020-2025)
 Table 67. Global Aurora Kinase B Revenue Market Share by Application (2026-2031)
 Table 68. Global Aurora Kinase B Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Aurora Kinase B Price (USD/Pcs) by Application (2026-2031)
 Table 70. AbbVie Inc Company Information
 Table 71. AbbVie Inc Description and Business Overview
 Table 72. AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. AbbVie Inc Aurora Kinase B Product
 Table 74. AbbVie Inc Recent Developments/Updates
 Table 75. Advenchen Laboratories LLC Company Information
 Table 76. Advenchen Laboratories LLC Description and Business Overview
 Table 77. Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Advenchen Laboratories LLC Aurora Kinase B Product
 Table 79. Advenchen Laboratories LLC Recent Developments/Updates
 Table 80. Aeterna Zentaris Inc Company Information
 Table 81. Aeterna Zentaris Inc Description and Business Overview
 Table 82. Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Aeterna Zentaris Inc Aurora Kinase B Product
 Table 84. Aeterna Zentaris Inc Recent Developments/Updates
 Table 85. Amgen Inc Company Information
 Table 86. Amgen Inc Description and Business Overview
 Table 87. Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Amgen Inc Aurora Kinase B Product
 Table 89. Amgen Inc Recent Developments/Updates
 Table 90. AstraZeneca Plc Company Information
 Table 91. AstraZeneca Plc Description and Business Overview
 Table 92. AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. AstraZeneca Plc Aurora Kinase B Product
 Table 94. AstraZeneca Plc Recent Developments/Updates
 Table 95. Chipscreen Biosciences Ltd Company Information
 Table 96. Chipscreen Biosciences Ltd Description and Business Overview
 Table 97. Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Chipscreen Biosciences Ltd Aurora Kinase B Product
 Table 99. Chipscreen Biosciences Ltd Recent Developments/Updates
 Table 100. Cielo Therapeutics Inc Company Information
 Table 101. Cielo Therapeutics Inc Description and Business Overview
 Table 102. Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Cielo Therapeutics Inc Aurora Kinase B Product
 Table 104. Cielo Therapeutics Inc Recent Developments/Updates
 Table 105. Sanofi Company Information
 Table 106. Sanofi Description and Business Overview
 Table 107. Sanofi Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Sanofi Aurora Kinase B Product
 Table 109. Sanofi Recent Developments/Updates
 Table 110. Sareum Holdings Plc Company Information
 Table 111. Sareum Holdings Plc Description and Business Overview
 Table 112. Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. Sareum Holdings Plc Aurora Kinase B Product
 Table 114. Sareum Holdings Plc Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Aurora Kinase B Distributors List
 Table 118. Aurora Kinase B Customers List
 Table 119. Aurora Kinase B Market Trends
 Table 120. Aurora Kinase B Market Drivers
 Table 121. Aurora Kinase B Market Challenges
 Table 122. Aurora Kinase B Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Aurora Kinase B
 Figure 2. Global Aurora Kinase B Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Aurora Kinase B Market Share by Type: 2024 & 2031
 Figure 4. AZD-2811 Product Picture
 Figure 5. CS-2164 Product Picture
 Figure 6. Danusertib Product Picture
 Figure 7. Ilorasertib Product Picture
 Figure 8. NMI-900 Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Aurora Kinase B Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Aurora Kinase B Market Share by Application: 2024 & 2031
 Figure 12. Anaplastic Large Cell Lymphoma
 Figure 13. Kidney Cancer
 Figure 14. Lung Cancer
 Figure 15. Prostate Cancer
 Figure 16. Others
 Figure 17. Global Aurora Kinase B Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Aurora Kinase B Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Aurora Kinase B Sales (2020-2031) & (K Pcs)
 Figure 20. Global Aurora Kinase B Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Aurora Kinase B Report Years Considered
 Figure 22. Aurora Kinase B Sales Share by Manufacturers in 2024
 Figure 23. Global Aurora Kinase B Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Aurora Kinase B Players: Market Share by Revenue in Aurora Kinase B in 2024
 Figure 25. Aurora Kinase B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Aurora Kinase B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Aurora Kinase B Sales Market Share by Country (2020-2031)
 Figure 28. North America Aurora Kinase B Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Aurora Kinase B Sales Market Share by Country (2020-2031)
 Figure 32. Europe Aurora Kinase B Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Aurora Kinase B Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Aurora Kinase B Revenue Market Share by Region (2020-2031)
 Figure 40. China Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Aurora Kinase B Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Aurora Kinase B Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Aurora Kinase B Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Aurora Kinase B Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Aurora Kinase B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Aurora Kinase B by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Aurora Kinase B by Type (2020-2031)
 Figure 62. Global Aurora Kinase B Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Aurora Kinase B by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Aurora Kinase B by Application (2020-2031)
 Figure 65. Global Aurora Kinase B Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Aurora Kinase B Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Aurora Kinase C Market Research Report 2024
Global Aurora Kinase B Antibody Market Research Report 2024
Global Aurora Kinase B Protein Market Research Report 2024
Global Aurora Kinase A Antibody Market Research Report 2024
Global Apatinib Market Research Report 2024
Global Protein Tyrosine Kinase Market Research Report 2025
Global Neratinib Market Research Report 2024
Global Fostamatinib Market Research Report 2024
Global Tyrosine Protein Kinase ITK Market Research Report 2024
Global Protein Kinase C Theta Market Research Report 2024
Global Afatinib Market Research Report 2024
Global Amazon Aurora Consulting Service Market Research Report 2024
Global Alectinib Market Research Report 2024
Global Kinase Biology Services Market Research Report 2025
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Research Report 2025
Global Aurora Kinase B ELISA Kit Market Research Report 2024
Global Tyrosine Protein Kinase CSK Market Research Report 2024
Global Ibrutinib Market Research Report 2024
Global Ice Skates Market Research Report 2024
Global Janus Kinases Inhibitor Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions